Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
about
Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complexLow aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma.Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2AAn analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects.Hemangioblastoma of pelvic cavity: report of a case and review of literature.pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiationSporadic hemangioblastomas are characterized by cryptic VHL inactivation.HIF hydroxylation and the mammalian oxygen-sensing pathwaySomatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.Coexpression of transforming growth factor-alpha and épidermal growth factor receptor in capillary hemangioblastomas of the central nervous systemInternal en bloc resection and genetic analysis of retinal capillary hemangioblastoma.Expression of the Von Hippel-Lindau tumor suppressor gene, VHL, in human fetal kidney and during mouse embryogenesisThe molecular basis of von Hippel-Lindau diseaseElongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products.Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma.Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.Transcription syndromes and the role of RNA polymerase II general transcription factors in human disease.A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implicationsMutations in the von hippel-lindau tumour suppressor gene in central nervous system hemangioblastomasSoftware and database for the analysis of mutations in the VHL gene.Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter.Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system.Molecular genetic diagnosis of von Hippel-Lindau disease: analysis of five Japanese families.Management Strategies and Outcomes for VHL-related Craniospinal Hemangioblastomas.Pathological and Clinical Features and Management of Central Nervous System Hemangioblastomas in von Hippel-Lindau Disease.Von Hippel-Lindau disease.Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families.
P2860
Q24523680-1E1AF969-8199-4E7F-ACDE-3B0694C080C9Q28582367-F443FE61-2C6D-4F6E-9F04-7BDCAE97C49BQ33557931-FA5A0FB1-0E62-470E-987A-F01B1B548553Q33677726-56A46E2C-4BDA-4FD6-9927-0443DBA4C4A4Q34387297-87C4D39A-0BBA-46C2-B436-234BC68B2559Q34502084-17421133-ACC2-406D-8D9C-D88D3695C3BBQ34753344-3F934543-7AC8-47B7-A797-4C3A90488468Q34979062-3B1F362A-80D6-4270-A2DB-76E68E80D034Q35086143-B0883958-30B8-43B4-BA82-9CBA51A365E5Q35238725-F7ED577B-E7D2-4BB3-90BB-47FB2BCEAFF9Q35462032-4714C74E-B16C-40AC-AC06-FEA0FF87DEDBQ35763943-44D66492-EBF7-4174-8C86-EF9DE8F326EAQ35796053-9DC00DF0-38E2-4FE3-8F83-21C537D88BDFQ36275123-0C5031DA-43F1-4C2F-B42E-FB4B45A9F1E0Q36437594-12CA5F62-7A36-48FA-A610-47E7E585D76EQ36437759-B796FB9B-35D2-46ED-96E2-FC5D7732E7E7Q37230912-E11BE306-A961-410C-AD03-E4F32C332463Q37231081-9065A1F2-4C37-4FFB-8F7C-084E96A02973Q37286026-5D97BD32-C40E-4D38-B03C-7CC1B0B96C37Q37353465-5605A3F3-EC2B-43BB-9AFB-84A761E2F68AQ37370106-621C73FA-196D-4ABB-9813-F4583FFBE49BQ38449441-4A8AA37A-FC0D-44DD-A71F-F521958FD4D4Q39722266-F655E177-C65C-484B-9E42-486E0A88876AQ40718800-82883466-E36C-44C7-A8D6-9E44DFADB183Q48229243-E2EB5330-9251-4F41-98E3-D1A57C82771AQ50092603-17E634F5-72F9-42B7-A968-CDFAC1CB96F0Q53086275-C591B649-8F67-452C-9C01-B68ED19EE1C0Q54135611-5041F332-2599-4B84-8913-DC525A4923CBQ54863226-2A68A7EF-CDAD-4F0A-9C73-BF094FD43E16Q55312690-37FF2285-1A2B-4CFE-BE0E-41A748906E30
P2860
Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Somatic mutations of the von H ...... vous system hemangioblastomas.
@ast
Somatic mutations of the von H ...... vous system hemangioblastomas.
@en
Somatic mutations of the von H ...... vous system hemangioblastomas.
@nl
type
label
Somatic mutations of the von H ...... vous system hemangioblastomas.
@ast
Somatic mutations of the von H ...... vous system hemangioblastomas.
@en
Somatic mutations of the von H ...... vous system hemangioblastomas.
@nl
prefLabel
Somatic mutations of the von H ...... vous system hemangioblastomas.
@ast
Somatic mutations of the von H ...... vous system hemangioblastomas.
@en
Somatic mutations of the von H ...... vous system hemangioblastomas.
@nl
P2093
P1433
P1476
Somatic mutations of the von H ...... rvous system hemangioblastomas
@en
P2093
Yamamoto I
P304
P407
P577
1994-09-01T00:00:00Z